Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure (PREVENTA)

AstraZeneca

Status: Completed

Conditions: Blood Pressure

Study type: Observational

Funder types: Industry

Identifiers

NCT00925470

NIS-CFR-DUM-2009/1

Details and patient eligibility

About

Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.

Enrollment: 1,200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Adults with hypertension (treated or not), without known cardiovascular or renal disease.

Trial design

1,200 participants in 1 patient group

1